Personalis(PSNL) Stock Price Today | Quotes & News

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Personalis Management to Meet With Lake Street
TipRanksMay 1 10:55 ET
Earnings Preview: Personalis to Report Financial Results Post-market on May 06
Moomoo NewsApr 30 21:00 ET
Lake Street Maintains Personalis(PSNL.US) With Buy Rating, Maintains Target Price $9
Moomoo NewsApr 30 07:31 ET · Ratings
Craig-Hallum Maintains Personalis(PSNL.US) With Buy Rating
Moomoo NewsApr 30 07:31 ET · Ratings
Personalis (PSNL) Gets a Buy From Lake Street
TipRanksApr 29 08:58 ET · Ratings
Personalis' NeXT Personal Detects 100% of Colorectal Cancer Relapses Ahead of Imaging in VICTORI Cancer Study
BusinesswireApr 28 17:00 ET

Comments

Teddy123

Apr 29 13:41

Personalis’ NeXT Personal® Detects 100% of Colorectal Cancer Relapses Ahead of Imaging in VICTORI Cancer Study

$Personalis (PSNL.US)$
Breakthrough: New Cancer Blood Test Detects Colorectal Relapses Months Before Imaging

Teddy123

Apr 22 18:02

Personalis and Academic Partners to Present Latest Data on Ultrasensitive ctDNA Test for Residual Cancer and Recurrence Detection

$Personalis (PSNL.US)$
Groundbreaking Cancer Detection Test Achieves Major Clinical Milestone: Results From 15+ Cancer Types

MoneyForNothing

Mar 13 01:19

$Personalis (PSNL.US)$ this one needs volume

Jaguar8

Mar 4 10:36

🔵Watchlist, MARCH 4,2025, Tuesday. NFA -DrJag8

NOTE!
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If you...

19

13

Trytosaveabit

Mar 3 19:06

Encouraging

$Personalis (PSNL.US)$ Personalis' Ultra-Sensitive Blood Test Detects Breast Cancer Recurrence Up to 5 Years Early
Benzinga· just
Personalis, Inc. (NASDAQ:PSNL), in collaboration with Professor Nick Turner, Dr. Isaac Garcia-Murillas and their colleagues at The Institute of Cancer Research, London and The Royal Marsden NHS Foundation Trust in the UK, published results from their early-stage breast cancer study in Annals of Oncology. In this groundbreaking study, the authors highlight ad...

1

PSNL Personalis

Trade Overview

Capital Trend

News

Comments

Market Insights

Latest News

Investment Course

Discussing

Monetary Policy: Navigating the Fed's Rate Cut Cycle